Lineage Cell Therapeutics Inc (LCTX)
1.145
-0.06
(-4.58%)
USD |
NYAM |
Apr 19, 16:00
1.145
0.00 (0.00%)
After-Hours: 16:02
Lineage Cell Therapeutics Cash from Operations (TTM): -28.57M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.57M |
| September 30, 2023 | -30.85M |
| June 30, 2023 | -31.29M |
| March 31, 2023 | -32.09M |
| December 31, 2022 | 1.059M |
| September 30, 2022 | 3.489M |
| June 30, 2022 | 4.121M |
| March 31, 2022 | 5.767M |
| December 31, 2021 | -23.56M |
| September 30, 2021 | -23.33M |
| June 30, 2021 | -23.33M |
| March 31, 2021 | -22.15M |
| December 31, 2020 | -19.75M |
| September 30, 2020 | -19.64M |
| June 30, 2020 | -22.23M |
| March 31, 2020 | -27.66M |
| December 31, 2019 | -31.95M |
| September 30, 2019 | -32.24M |
| June 30, 2019 | -32.12M |
| March 31, 2019 | -29.86M |
| December 31, 2018 | -30.88M |
| September 30, 2018 | -30.74M |
| June 30, 2018 | -31.09M |
| March 31, 2018 | -32.76M |
| December 31, 2017 | -30.52M |
| Date | Value |
|---|---|
| September 30, 2017 | -33.69M |
| June 30, 2017 | -34.93M |
| March 31, 2017 | -36.11M |
| December 31, 2016 | -42.33M |
| September 30, 2016 | -47.42M |
| June 30, 2016 | -50.07M |
| March 31, 2016 | -49.79M |
| December 31, 2015 | -44.54M |
| September 30, 2015 | -39.71M |
| June 30, 2015 | -36.76M |
| March 31, 2015 | -37.57M |
| December 31, 2014 | -38.85M |
| September 30, 2014 | -38.37M |
| June 30, 2014 | -36.18M |
| March 31, 2014 | -32.84M |
| December 31, 2013 | -29.51M |
| September 30, 2013 | -25.88M |
| June 30, 2013 | -24.47M |
| March 31, 2013 | -20.98M |
| December 31, 2012 | -19.68M |
| September 30, 2012 | -18.53M |
| June 30, 2012 | -17.12M |
| March 31, 2012 | -15.95M |
| December 31, 2011 | -13.59M |
| September 30, 2011 | -12.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-32.24M
Minimum
Sep 2019
5.767M
Maximum
Mar 2022
-20.33M
Average
-23.33M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Sarepta Therapeutics Inc | -500.99M |
| Acumen Pharmaceuticals Inc | -43.06M |
| CEL-SCI Corp | -23.07M |
| AIM ImmunoTech Inc | -21.27M |
| IGC Pharma Inc | -6.19M |